Monitoring migration and ethnicity related indicators in European Drug Treatment Demand Registries by De Kock, Charlotte
                                          Day 1: Wednesday, May 22nd 
8:00 to 9:00 AM Registration 
9:00 to 9:20 AM Opening and welcome 
Marie Jauffret-Roustide, Paris Conference Host  
Alex Stevens, President of the ISSDP 
Anne Souyris, Paris Deputy Major in charge of health issues 
9:20 to 10:20 AM First plenary session: “The ontological politics of drug policy: a critical realist approach” 
 
Keynote presentation by Alex Stevens, Professor in Criminal Justice, University of Kent 
in conversation with Kari Lancaster, Senior Research Fellow at UNSW   
and Rosalie Liccardo Pacula, Co-Director of the RAND Drug Policy Research Center 
 
Chair: Alison Ritter 
10:20 to 10:50 AM Break 
10:50 AM to 12:20 PM Exploring changes in 
the US 'heroin' risk 
environment: HIV, drug 
supply, polysubstance 
use and overdose 
The roles of measures 
and perceptions in 
cannabis regulation 
Cryptomarkets: supply, 
demand, and hidden 
spaces of transaction 
New models for public 
health treatment 
funding and 
enforcement 
Age, gender, family and 
perception factors in 
access to drug treatment 
and services 
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair Dan Ciccarone Beau Kilmer Gary Potter Anne Line Bretteville-Jensen Karine Bertrand 
 D. Ciccarone, J. Ondocsin,   
J. Fessel & Sarah Mars 
 
Missed opportunities: viral 
transmission risks among a 
new cohort of injectors in the 
United States “heroin” 
epidemic 
Yuyan Shi & D. Liang 
 
The associations between 
recreational cannabis 
commercialization and 
cannabis exposures reported 
to the US National Poison 
Data System, 2010-2017 
Michala Kowalski,  
J. Aldridge, R. Coomber,  
J. Martin & M.J. Barratt 
 
Cryptomarkets, ignorance 
and harm: does drug 
expertise matter more in a 
high drug availability setting? 
Osasuyi Dirisu & 
A. Klein 
 
Non-medical use of tramadol 
in West Africa: The tensions 
between law enforcement, 
illegal supply pathways and 
public health. 
Mélanie Quétier,                    
M. Bouchon, N.N. Lwin & 
S.N. Pan 
 
Sociocultural and religious 
norms and values at the 
foundation of repression and 
violence towards people who 
use drugs in Kachin State, 
Myanmar 
 Dan Rosenblum, G.J. Unick 
& D. Ciccarone 
 
The rapidly changing US 
illicit opioid market and the 
potential for an improved 
early warning system: 
Evidence from Ohio drug 
crime labs 
David-Martin Milot &  
M. Jauffret-Roustide 
 
Psychoactive substances and 
their regulatory systems: how 
social representations 
influence policies in France 
Shann Hulme, C.E. Hughes 
& S. Nielsen 
 
The price of drugs supplied 
on the pharmaceutical black 
market: an Australian case 
study 
Chris Wilkins & M. Rychert 
 
The risks of cannabis 
industry funding of 
community and drug 
treatment services – Insights 
from gambling 
Meredith Meacham,  
K. Lynch, P. Coffin &  
E. Riley 
 
An examination of fentanyl 
metabolites in a primarily 
crack cocaine-using 
population of unstably 
housed women in San 
Francisco, USA 
 Georgiy Bobashev,               
L. Warren, N. Peiper &       
D. Ciccarone 
 
Polydrug use patterns among 
prescription opioid misusers 
and heroin users. Results 
from the National Household 
Survey of Drug Use and 
Health 
L. Beltz, Clayton Mosher &  
J. Schwartz  
 
Assessing perceived effects of 
1-502: A survey on 
recreational cannabis in 
Washington State 
 
Patrick Shortis  
 
Towards an understanding of 
resilience in cryptomarkets 
 
Jorge Mantilla 
 
Supply resilience and 
therapeutic policing: the new 
face of war on drugs in 
Colombia 
 
Maria Caiata-Zufferey,  
M. Luciani, P. di Giulio,  
L. Pezzoli, C. Prandi &  
A. Moriggia 
 
The aging process of people 
who use drugs in opioid 
substitution treatment: design 
and preliminary results of an 
interdisciplinary and 
participatory research project 
in Southern Switzerland 
 George Jay Unick,               
D. Rosenblum &                  
D. Ciccarone 
 
Divergence in deaths vs. 
hospitalizations for heroin 
and other opiate overdoses. 
Changes in risk or problems 
of classification? 
Clayton Mosher 
 
Youth use of marijuana in 
Washington State - Trends 
and correlates 
 
Nicolae Craciunescu 
 
Drugs in the context of 
consumer culture: the sign-
value of the products sold on 
the Darknet marketplaces 
 
Aysel Sultan 
 
The stake of a non-standard 
comparative approach: 
Treatment policies of 
Azerbaijan and Germany 
 
Sarah A. Daniels,  
T.A. Sanchez, M. St. Pierre & 
Z. Walsh 
 
Maternal cannabis use: 
Examining the relationships 
between cannabis use, 
attachment, and parenting 
outcomes in Canadian 
mothers 
 
12:20 PM to 1:30 PM 
 
Lunch break 
 
12:20 PM to 1:30 PM 
 
Poster presentations (R2-01) 
1:30 PM to 3:00 PM National and cultural 
contexts: comparative 
drug policy analysis 
Policy controversies 
about harm reduction 
Cannabis: consumer 
experiences and 
evolving perceptions 
Legalizing, 
implementing, and 
assessing substitution 
treatment 
Measuring, treating, and 
prohibiting drug use 
among marginalized 
and migrating drug 
users 
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair Scott Burris Naomi Burke-Shyne David-Martin Milot Polly Radcliffe Bernd Werse 
 Siobhan Callaghan 
 
Issues in comparing national 
drug policies: Utilising 
typologies to identify drug 
policy regimes and explore 
cultural contexts 
 
 
Tuukka Tammi 
 
Political process on launching 
drug consumption rooms in 
Helsinki 
 
Ashely Granville, J. Chopin, 
P. Esseiva, R. Udrisard,  
F. Zobel, & M. Jendly  
 
Lights on small-scale 
cannabis growers: Findings 
from a European web survey 
and face to face interviews 
Sarah Heins & R. Castillo  
 
Evaluation of the impact of 
morphine equivalent daily 
dose policies on high dose 
opioid prescribing 
 
Louise Christensen, B. Bjerge 
& E. Houborg 
 
Agents of care and control 
within the welfare State: The 
interrelation between drug 
policies, social policies and 
services towards people who 
experience social 
marginalization 
 Kim Moeller 
 
Sisters are never alike? – 
Drug control intensity in the 
Nordic countries 
Marie Jauffret-Roustide &  
I. Cailbault 
 
Controversy over drug 
consumption rooms: from 
assessing social acceptability 
to sharing urban spaces 
 
 
Daniel Bear 
 
Young people's decision 
making about cannabis 
Atul Ambekar, R. Rao,  
A. Agrawal, S. Singh &  
M. Varshney  
 
Ambiguities in the legal 
frameworks for treatment of 
drug use disorders versus 
other mental health 
conditions: Reflections from 
the recently enacted mental 
healthcare law in India 
 
 
Charlotte De Kock 
 
Monitoring migration-related 
indicators in European drug 
treatment: Identifying pitfalls 
and challenges in registration, 
data collection and database 
coupling methods 
 Clara Musto 
 
Advocacy coalitions moral 
foundations: developing 
cross-cultural variations in 
drug policy change 
explanations 
 
 
Esben Houborg, 
M. Bancroft & 
J. Wielandt Holt  
 
The impact of a local drug 
policy on drug users’ 
everyday life on an open drug 
scene 
 
Sharon R. Sznitman, 
Y. Ben Baruch, T. Greene & 
M. Gelkopf 
 
The association between 
physical pain and cannabis 
use in daily life: An 
experience sampling method 
Pedro Mateu-Gelabert,  
H. Guarino & S. Campos 
 
Atención VIH (A!VIH): An 
integrated Seek, Test, Treat 
and Retain (STTR) - 
Medication-Assisted 
Treatment (MAT) 
intervention for PWID in 
Latin America 
Sarah Tosh 
 
Drug prohibition and the 
criminalization of 
immigrants: The 
compounding of drug war 
disparities in the modern 
United States deportation 
regime 
 
 R. Kert, A. Lehner, Brendan 
Hughes & O. Dalbinoë 
 
Comparing drug trafficking 
penalties across the EU 
 
 
Tara Marie Watson,  
L. Barnaby, A.M. Bayoumi, 
L. Challacombe, A. Wright & 
C. Strike 
 
“This is a health service. 
Leave it alone”: Staff and 
client views on policing 
boundaries involving 
supervised consumption 
services 
Sebastian Aguiar 
 
What do people think 
afterwards? Characterizing 
public opinion on cannabis 
regulation in Uruguay 
through open-ended 
responses 
 
Samara Mayer, A. Fowler,  
J. Boyd & R. McNeil  
 
Understanding motivations 
for the initiation of injectable 
opioid agonist treatment: An 
ethnographic study of patient 
care experiences in 
Vancouver, Canada 
S. MacGregor &  
Aileen O'Gorman 
 
Social policy paradigms: 
framing perceptions and 
policies towards people who 
are poor and use drugs. 
3:00 PM to 3:30 PM Break 
3:30 PM to 5:00 PM  Illicit drugs and the 
transformation of war 
economies 
Opioid use and 
responses - Opioid crisis 
Methods in 
measurements and 
assessments of 
largescale drug policy 
Polyuse and issues in 
specific injecting 
communities 
Medical cannabis: use 
and regulations 
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair John Collins Peter Reuter Brendan Hughes Fay Dennis Sharon Sznitman 
 John Collins 
 
Theorising fragmentation and 
change in global drug control 
Bryce Pardo, B. Kilmer 
 
Why fentanyl in North 
America? Why now? 
Ayden Scheim,  
N. Maghsoudi, S. Churchill, 
Z. Marshall & D. Werb  
 
What matters and what has 
been measured? A systematic 
review of research on the 
Jennifer Havens &  
H. Knudsen  
 
Recent transition to 
methamphetamine use 
among nonmedical 
prescription opioid users 
Bernd Werse, L. Klaus &  
G. Kamphausen  
 
Hybrid users – results from a 
qualitative study on the 
blurred boundaries between 
recreational and medical 
impacts of implementing 
drug decriminalization or 
regulation 
from Appalachian Kentucky, 
2008-2019 
 
cannabis use 
 
 Jasmine Bhatia 
 
Unsettling the peace? The 
role of illicit economies in 
peace processes 
 
 
Jirka Taylor & P. Reuter 
 
International experiences 
with fentanyl 
Hannah Knudsen &  
J. Havens  
 
Using conjoint analysis to 
study health policy changes: 
an example from a cohort of 
persons who use drugs 
Katherine McLean, K. Rigg, 
S. Monnat, A. Verdery &  
G. Sterner  
 
“Pushed in the same way”: 
Exploring the role of cocaine 
in heroin initiation, 
continuation, and desistance 
Frédérique Bawin 
 
Accessing illicit medicines. 
The search for medicinal 
cannabis in Flanders 
 
 
 Jonathan Goodhand 
 
Re-imagining the narco 
frontier 
Rosanna Smart & B. Kilmer 
 
Can heroin-assisted treatment 
help reduce fentanyl deaths in 
the US? 
Nicola Singleton, D. Ballotta, 
C. Costa Storti, E. Quigley & 
L. Vandam  
 
“Help! I have to evaluate our 
drug strategy” – the 
EMCDDA approach to 
promoting an evaluation 
culture in drug policy 
development in Europe 
Laurent Gaissad, 
T. Madesclaire & M. Milhet 
 
Combining strategies:  echoes 
from the APACHES 
chemsex study in France 
Chelsea Cox 
 
One stream or two stream? 
Legal and policy 
considerations for 
maintaining a separate 
medical cannabis access 
stream in Canada 
 Eric Gutierrez 
 
The paradox of illicit 
economies 
Jennifer Hasselgard-Rowe 
 
Cambodia’s legal and judicial 
structure: a serious 
impediment to reforming the 
country’s drug policies and 
practices   
Davide Fortin & M. Pardal 
 
In between recreational and 
medical cannabis supply 
models: is the Cannabis 
Social Club a potential buffer 
against market distortions? 
Roberto Abadie 
 
Poverty, homelessness and 
barriers to access and 
retention in opioid agonist 
therapy for people who inject 
drugs 
Mark Monaghan, E. Wincup 
& I. Hamilton 
 
Scandalous decisions: 
Understanding UK medicinal 
cannabis policy 
5:00 PM to 6 :00PM  
ISSDP General Assembly – R2-01 
 
7:00 PM to 9:00 PM  
Reception 
 
                                         Day 2: Thursday, May 23rd 
8:15 AM to 8:45 AM Registration 
8:45 AM to 9:45 AM Second plenary session: “Collaborating with peers in alcohol and other drug (AOD) research”  
 
Presentation by Jo Neale, Professor of Addictions Qualitative Research at King’s College, London,   
in conversation with Jean-Maxence Granier of ASUD (the French drug users’ association) 
 
Chair: Marie Jauffret-Roustide 
9:45 AM to 10:00 AM Short break 
10:00 AM to 11:30 AM Advances in 
decriminalization 
efforts: theory and 
practice 
Drug-related deaths as a 
public health problem: 
knowing, testing, 
responding 
Measuring and 
preventing overdoses: 
individuals and 
community involvement 
Results and lessons 
learned after five years of 
cannabis regulation in 
Uruguay   
Drug Policies in African 
countries (Satellite Session 
organized by the Open 
Society Foundation) 
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair Willy Pedersen Alex Stevens Charlie Lloyd Sebastian Aguiar Fabrice Olivet, Abdou 
Ndiaye & Samuel Roberts 
 Pekka Hakkarainen 
 
Decriminalization debate in 
Finland  
Basak Tas 
 
Heroin overdose: Improving 
understanding through 
laboratory investigation 
 
Amanda Roxburgh, W. Hall, 
& L. Degenhardt  
 
Correlates of opioid overdose 
deaths: do they differ 
between opioids? 
Marcos Baudean 
 
Five years of cannabis 
regulation in Uruguay: what 
are the changes in health, 
security and justice? What 
can we learn from the 
Uruguayan experience of 
regulation? 
Shaun Shelly 
 
Peer involvement and drug 
user's activism in South 
Africa 
 Jonas von Hoffmann  
 
Cutting through the celeste 
haze: An assessment of the 
determinants of drug policy 
reform in Uruguay 
 
 
Fay Dennis 
 
Accounting for overdose 
among older people who use 
heroin in the UK: A 
challenge to the ageing 
cohort theorem 
 
Karla D. Wagner, R. Harding, 
E. Copulsky, S. Verdugo,  
R. Kelley, B. Labus,  
J. Bowles, M.L. Mittal &  
P.J. Davidson  
 
Interventions triggered by 
calling 911 to seek emergency 
Mauricio Coitiño, S. Aguiar, 
F. Lemos & C. Musto 
 
Marijuana on the media in 
the era of regulation in 
Uruguay: 2013-2017 
Albert Gautier Ndione 
 
Drug use, discrimination and 
difficulties in organizing drug 
users 
medical assistance for 
overdose in the US: 
Centering the perspectives of 
people who use drugs 
 Caitlin Hughes, A. Stevens, 
S. Hulme & R. Cassidy  
 
Models for the 
decriminalisation, 
depenalisation and diversion 
of illicit drug possession: An 
international realist review 
 
Andrew McAuley 
 
What difference does it 
make? Assessing the impact 
of take-home naloxone scale 
up internationally 
 
 
Penelope Hill, P. Agius,  
M. Stoove, M. Hickman,  
L. Maher & P. Dietze 
 
Recent non-fatal opioid 
overdose:  The effects of 
health service utilisation, 
alcohol and other drug use 
and demographic factors 
among people who inject 
drugs in Melbourne, Australia 
F. Figari, S. Aguiar, F. Lemos 
& Clara Musto 
 
In the backyard: Cannabis 
self-cultivation in Uruguay, 
2014-2018 
Ousmane Gaye 
 
The role of Francophonie in 
the creation of a project for 
self-support groups in 
Senegal and in Africa 
(RAFASUD vs 
AFRICAPUD) 
 Larissa J. Maier, J. A. Ferris, 
M.J. Barratt & A.R. Winstock 
 
THC-infused – Analysis of 
edible and other cannabis use 
considering policy contexts in 
14 countries 
Zoe Carre & A. Ali 
 
Monitoring the availability 
and accessibility of take-
home naloxone across 
England in 2017/18 
 
 Lorena Repetto 
 
The impact of marijuana sale 
at pharmacies on crime. A 
natural experiment 
James Ndimbii &  
Fanny Procureur 
 
Harm reduction and peer-
centered solutions in Kenya  
 
11:30 AM to 11:45 AM Break 
11:45 AM to 1:15 PM Cannabis legal and 
illegal market studies 
Impact of cannabis 
policing on 
consumption and 
communities 
The policing of 
international drug 
policies in Mexico 
 
Drug policy as 
scapegoating: 
Explanations and effects 
Race in the U.S. Opioid 
crisis (Satellite Session 
organized by the Drug 
Policy Alliance 
Room Auditorium R2-01  R1-13 R1-14 R1-15 
Chair Neil Boyd David-Martin Milot Alejandro Madrazo Lajous Alex Stevens Jules Netherland 
 Eliana Álvarez  
 
Marijuana risk perception and 
consumption levels: a natural 
experiment with the 
Charlie Lloyd 
 
Lacking purpose: the policing 
of cannabis possession in the 
North of England 
Claire Moon 
 
Delusions and lies: death 
denial in Mexico’s war on 
drugs 
David Brewster 
 
Migattena Ponchu (the selfish 
drug addict)? Culturing 
responses to drug use in 
Samuel Roberts 
 
Race, national belonging and 
the framing of drug scares 
pharmacies’ sales mechanism 
in Uruguay 
 Japan 
 Rosalie Liccardo Pacula 
 
The development of new 
measures of cannabis market 
exposure:  A case study in 
Colorado 
 
Marvin Krank, T. Sanchez, 
M. Pilin & J. Robinson 
 
Changing how youth think 
about cannabis: The impact 
of legalization in Canada on 
under-aged youth 
Javier Trevino-Rangel 
 
Torture manual: the social 
control of illicit drugs  
in Mexico 
 
Jack Spicer 
 
Between gang talk and 
prohibition: Scapegoating and 
the transfer of blame for 
County Lines 
Helena Hansen 
 
White racial marketing as 
driver of opioids in the US 
 Aaren Ivers & N. Boyd 
 
Canada’s mail order 
marijuana (MOM) market: 
Illicit online cannabis sales 
and the implications of 
legalization 
 
Ivana Obradovic 
 
A comparative perspective on 
the emerging cannabis 
regulatory frameworks: first 
outcomes and unintended 
consequences (Uruguay, USA 
and Canada) 
A. Madrazo Lajous, Rebeca 
Calzada Olvera &  
J. J. Romero Vadillo 
 
The “War on Drugs”: 
Analysis of battles involving 
Public forces, 2006-2011 
 
Liviu Alexandrescu & Emma 
Wincup 
 
Vindictive times: 
scapegoating destitute drug 
users 
 
Pedro Mateu-Gelabert 
 
Opioid epidemic in the US: 
newfound sympathy for 
opioid users along with 
traditional punitive criminal 
justice 
 Adam Orens & M. Light 
 
Colorado market evolution – 
5 years in 
 
Renaud Colson 
 
Challenging cannabis 
prohibition with doctrinal 
writing 
 
Nidia Andrea Olvera 
Hernández 
 
The origins of prohibition 
and drug policy in México: 
Lessons from the past 
Judy Chang & Shaun Shelly 
 
The burden of blame:  
People who use drugs as a 
politically expedient target 
 
 
 
1:15 PM to 2:30 PM  Lunch 
2:30 PM to 4 :00 PM The impact of 
decriminalization and 
legalization on issues of 
crime, race, and user 
perception 
Not-for-profit models 
for regulated cannabis 
markets 
Harm reduction as 
prevention: naloxone 
and digital monitoring  
Alcohol, tobacco and 
other drug policies   
Peer and other 
stakeholders' 
involvement in 
participatory research on 
harm reduction 
programs  
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair Caitlin Hughes Simon Lenton Andrew McAuley Esben Houborg Marie Jauffret-Roustide 
 Edwin Grimsley 
 
Decriminalization, 
racialization and 
criminalization: Toward a 
theory of legalization policy 
for marijuana in New York 
City 
 
 
Tom Decorte, M. Pardal,  
M. Bone, O. Pares &  
J. Johansson 
 
Mapping cannabis social 
clubs in Europe 
Róbert Csák, J. Arsenijevi,    
P. Sárosi, I. Molnar & 
B. Arsenijevi 
 
Different environments, 
different risk behaviors: 
Consequences of decreased 
coverage of needle exchange 
programs in Budapest and 
Belgrade 
Thomas Kattau 
 
Towards a new balanced 
approach: Ensuring public 
health and safety while 
guaranteeing individual rights 
 
Jean-Michel Delile & Jean-
Hugues Morales,  
K. Bertrand, J. Flores-
Aranda, J. Tremblay,               
S. Brochu, E. Roy,  
J. D. Mahoney, K. Alunni-
Menichini, A. C. Villela 
Guilhon & T. Haig 
 
The involvement of 
workplace and health care 
stakeholders in the 
development and 
implementation of TAPAJ, a 
comprehensive approach to 
harm reduction based on 
low-threshold work in 
Quebec and France 
 Rosario Queirolo, J.Bowers, 
E. Alvarez & L. Repetto  
 
The impact of marijuana sale 
at pharmacies on users’ 
stigmatization, law approval, 
insecurity perceptions and 
crime victimization 
 
Marta Rychert & C. Wilkins 
 
Could New Zealand’s 
community trust model for 
alcohol be applied to regulate 
legal cannabis? 
 
Vivienne Moxham-Hall,  
C. Hughes & A. Ritter  
 
Lost in translation? The 
effect of good samaritan and 
naloxone opioid overdose 
prevention laws “on the 
books” on opioid overdose 
mortality rates in the United 
States 
Claudia Costa Storti, 
B. Casal & D. Morgan 
  
How much does drug and 
alcohol hospital treatment 
cost in Europe? 
 
 
 
Michel Perreault & 
Guillaume Tremblay,  
A-C. Artunduaga, C. Perron, 
C. Marshall &  
D. Milton  
 
Perceived impact of 
participation in a peer-
training overdose prevention 
program 
 
 Catalina Perez Correa &  
A. Ruiz 
 
In the name of public health: 
marijuana eradication and use 
of paraquat in Mexico 
 
E. Álvarez, Mafalda Pardal, 
R. Queirolo & L. Repetto 
 
Uruguayan cannabis social 
clubs: From activism to 
dispensaries? 
Magali Martinez, M. Pazitny 
& V. Belackova 
 
Fentanyl and opioids NPS: 
Catching low digital signals 
for preventing public health 
crisis 
Claire Wilkinson 
 
From “public need” to 
“public interest”: 
Comparative analysis of 
liquor licensing tests in 
Australian jurisdictions 
Karine Bertrand & Shane 
Knight, J. Flores-Aranda,  
J. Tremblay, S. Brochu,        
É. Roy, J.D. Mahoney,      
J.M. Delile, J.H. Morales,     
K. Alunni-Menichini,           
A. C. Villela Guilhon, &       
T. Haig 
 
Young people’s perspectives 
on a harm reduction program 
based on low-threshold work:  
Insights for social and health 
policy 
 Anne Line Bretteville-Jensen 
& L. Gjersing 
 
To what extent will the drug-
crime nexus remain after 
drug laws liberalization? An 
examination of criminal 
charges among patients in 
treatment for cannabis use 
disorders and controls under 
varied drug policy regimes 
Alejandro Madrazo Lajous & 
C. Pérez Correa 
 
A proposal for marihuana 
legislation in Mexico 
 
 
Suzanna Nielsen & A. Olsen 
 
Using the behaviour change 
wheel to understand and 
address barriers to pharmacy 
naloxone supply 
Virginia Berridge 
 
E-cigarettes and policy 
responses: evidence, history 
and harm reduction 
 
 
 
4:00 PM to 4:30 PM Break 
4:30 PM to 6:00 PM Evaluation of cannabis 
consumption, 
legalization and an 
innovative approach 
Epidemiological and 
critical perspectives on 
the elimination of 
hepatitis C virus in 
people who inject drugs 
(INSHU Session)  
Community responses 
and outreach for 
prevention and harm 
reduction 
Global issues of drug 
policy and theoretical 
analytical models 
Latest evidence on illicit 
drug economies in 
developing countries 
 
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair Peter Reuter Sarah Larney Alison Ritter Nicola Singleton Daniel Brombacher 
 A. Moss, D. De Silva, S. Cox, 
C. Notley & Manish Nanda 
  
Capital Card® Evaluation 
 
 
Sarah Larney & J. Grebely 
 
Global epidemiology of 
hepatitis C in people who 
inject drugs 
Olanrewaju Onigbogi 
 
Willingness to participate in 
peer engagement efforts in 
drug policy among out-of-
school youths in Lagos, 
Nigeria 
Carla Rossi 
 
Epidemiological models of 
heroin epidemics and social 
outcomes to evaluate illicit 
drug policy in various 
countries    
J. Garcia-Yi, Anja Korenblik 
& A. Me       
 
Evidence for policy-making: 
the number of households 
involved in illicit drug crop 
cultivation and the number of 
beneficiaries of alternative 
development 
 Pierre-Yves Geoffard 
 
Economic and fiscal impacts 
of cannabis legalisation in 
France 
 
 
Matt Hickman 
 
Epidemiology and public 
health surveillance of HCV 
prevention in people who 
inject drugs 
Mary Ellen Harrod,  
N. Lintzeris, L. Monds,  
M. Bravo, M. Joyce,  
P. Read & S Nielsen 
 
The NSW ORTHN Project: 
Implementing THN 
programs across AoD, NSP 
and outreach services 
Artur Malczewski, K. Abel-
Ollo, L. Isajeva &  
L. Jurgelaitienė  
 
Opioid-related problems in 
Baltic States and Poland: Has 
the turning point come? 
 
 
Juan Carlos Garzón Vergara, 
J.M. Rozo, J.D. Gélvez, C.M. 
Galeano & G.J. Romero 
 
The weakest link: A socio-
demographic characterization 
of small coca growers in 
Putumayo, Colombia 
 
 
 Megan Weier 
 
Exploring different 
“evidences” in Australian 
medicinal cannabis policy 
 
Kari Lancaster & T. Rhodes 
 
Performing hepatitis C 
elimination: A critical 
examination of productive 
capacity and constitutive 
effects of target-setting 
Michelle Van Impe 
 
Who are we and what do we 
want? Critical participatory 
action research with people 
who use illegal drugs 
Alexandra Scott 
 
Distribution of power among 
the global political actors 
along the Northern 
trafficking route. 
Deborah Alimi 
 
Illicit drug economies as a 
“development issue”? Survey 
of drug-related constraints on 
donors’ intervention and 
development cooperation in 
fragile contexts 
 Jasmina Burdzovic Andreas, 
A.L. Bretteville-Jensen & 
H. Gjerde 
 
Who lies about having used 
drugs?: Under-reporting of 
cannabis, cocaine, and ecstasy 
use in a sample of nightlife 
patrons in Norway 
Tim Rhodes & K. Lancaster 
 
Evidence-making elimination: 
Modelling, targets and the 
end of hepatitis C 
Alissa Greer 
 
Engaging the affected 
community in drug 
policymaking: Examining 
systems of inequity in peer-
based work among people 
who use drugs  
 
Lena Eriksson 
 
The ideological trade-off as 
the scientific epistemic 
culture meets the political: 
The case of needle exchange 
policy in Sweden 
 
Salwa Massad, H. Dalloul,    
A. Ramlwai, K.A. Saman,    
R. Salman & L.G. Johnston 
 
Estimating the extent of illicit 
drug use in Palestine: A 
cross-sectional study 
7:30 PM to 11:00 PM  
Conference dinner 
 
Address by Professor Peter Reuter 
 
  
 
 
 
                                         Day 3: Friday, May 24th 
8:00 AM to 8:30 AM Registration 
8:30 AM to 10:00 AM Analyses of global 
cannabis sales and 
regulation models 
Evolutions in policing 
among drug users and 
marginalized 
communities 
Applied innovations in 
analysis, interpretation 
and modeling 
International advances 
in harm reduction 
innovations 
Impact of drug policies 
on norms, communities, 
and social groups 
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair Tom Decorte Aili Malm Rosalie Liccardo Pacula Sam Shirley-Beavan Aileen O’Gorman 
 Toby Seddon &  
W. Floodgate 
 
Cannabis law reform: Global 
review and critical prospectus 
Tobias Kammersgaard 
 
From drug law enforcement 
to protection: Policing 
marginalized drug users after 
decriminalization 
Z. Walsh, Stacey Squires &  
S. Daniels 
 
The Index of Cannabis 
Equivalence (ICE); A new 
way to look at cannabis 
dosage 
Cameron Wild, J. Koziel,  
J. Anderson-Baron,  
M. Asbridge, L. Belle-Isle,  
C. Dell, R. Elliott,  
A. Hathaway,  
D. MacPherson, K. McBride, 
B. Pauly, C. Strike, K. Tupper 
& E. Hyshka  
 
Prevalence and correlates of 
support for harm reduction 
in a population survey of 
Canadian adults 
M. Germes, Luise Klaus 
 
Drug policies within urban 
spaces. Emo-mapping as an 
innovative qualitative 
cartography method 
 Neil Boyd 
 
Canada's legalization of 
cannabis: A patchwork quilt 
in progress? 
 
Michael White 
 
Exploring police officers’ use 
of de-escalation in encounters 
with intoxicated citizens 
 
E. Auriol, Alice Mesnard & 
T. Perrault 
 
Defeating crime? An 
economic analysis of 
cannabis legalization policies 
 
 
Alison Ritter 
 
Making drug policy in 
summer – Drug checking as 
providing more heat than 
light 
Simon Flacks 
 
School drugs policies: The 
politics of punishment 
 
 Robin Room 
 
Government monopoly as an 
instrument for public health 
and welfare: Lessons for 
Dina Perrone, A. Malm &  
E. Magana 
 
A process evaluation of Law 
Enforcement Assisted 
Emmanuelle Godeau,  
V. Ehlinger & S. Spilka 
 
EnCLASS: An innovative 
survey to contribute to drug 
Cecilia Comelli & E. Fahlke 
 
Night-time drug policies: 
How stakeholders make 
adjustments for 
Gideon Lasco & I. Feria 
 
The impacts of drug testing 
in Philippine schools 
cannabis from experience 
with alcohol and other 
public-interest monopolies 
Diversion (LEAD) 
implementation in California 
policies analysis among 
school-students in France 
implementing harm reduction 
strategies within festive 
settings in France 
 
 
 Patrick Oglesby 
 
Cannabis regulation models – 
Follow the revenue 
 
Kristelle Alunni-Menichini, 
K. Bertrand, L. Roy &  
A. Brousselle  
 
Current emergency response 
to homeless people who use 
psychoactive substances in 
Montreal: Results from a 
systemic and multi-
stakeholder perspective 
A. Abraham, Grace Adams, 
D. Bradford, A. Bradford & 
S. Harris 
  
Throwing good money after 
bad docs: The relationship 
between physician gifts and 
U.S. Department of Health 
and Human Services 
exclusion  
 Tatiana A. Sanchez,  
Z. Walsh, M. Krank,  
S.A. Daniels & M. St. Pierre 
 
The impact of cannabis 
legalization on the social 
norms of cannabis use in 
youth 
10:00 AM to 10:30 AM Break 
10:30 AM to 12:00 PM Global comparative 
policy analyses 
Issues of stigma in 
recovery and 
maintenance 
Cryptomarkets, 
amphetamines and LSD 
Gender issues, 
narratives, and violence 
 
Room Auditorium R2-01 R1-13 R1-14 R1-15 
Chair Alex Stevens Marie Jauffret-Roustide Michala Kowalski Kari Lancaster   
 Alejandra Cervantes Nieto 
 
The fight against drug 
trafficking in East Asia: A 
comparison of government 
policies designed to combat 
drug trafficking in China, 
Japan and the Philippines. 
 
 
Nguyen Thu Trang,  
M. Jauffret-Roustide,           
G. Le Minh & L. Visier 
 
How to be self-reliant within 
a context of stigma? The 
dilemma of injection drug 
users in Vietnam 
 
Sam Shirley-Beavan &  
K. Stone 
 
Amphetamine-type stimulant 
use: Global trends in the 
harm reduction response 
 
Polly Radcliffe, D. Gadd,  
B. Love, J. Henderson,  
D. Lewis-Jones, A. Johnson, 
L. Gilchrist & G. Gilchrist 
 
The contribution of 
substance use in intimate 
partner violence. Misuses of 
evidence in the England and 
Wales Domestic Abuse Bill 
2019 
 
 Maidina Rahmawati 
 
Lore Bellaert, F. Vander 
Laenen, C. Colman &  
P. Haave & Willy Pedersen 
 
M. Plotko, A. Kontautaite,  
D. Matyushina,  
 
Analyzing fair trial aspect of 
death penalty for drug cases 
in Indonesia: Policy and 
implementation: Special cases 
on women 
W. Vanderplasschen 
 
Recovery discourse in drug 
policies versus actual practice 
in Flanders (Belgium) 
The gradual ending of LSD-
based psychotherapy in 
Norway in the 1960s: moral 
panic or lack of evidence for 
its therapeutic efficacy?  
M. Golichenko, M. Kalvet, & 
E. Antonova 
 
Study of human rights 
violations faced by women 
who use drugs in Estonia 
 Emile Dirks 
 
China's war on drugs: 
Quantitative analysis of thirty 
years of policy successes and 
failures 
J. Aldridge, M. Barratt, 
Gary Potter & A. Ross 
 
“Coming out”: Stigma, 
reflexivity and the drug 
researcher’s drug use 
Thomas Friis Søgaard  
 
The ubernisation of drug 
markets: User motives for 
sourcing drugs from “ring 
and bring” delivery services 
 
Rebecca Askew 
 
Reflecting upon gendered 
narratives in discussions 
about drug policy and the law 
 
 
 Marie Nougier 
 
Taking stock of the past 
decade of UN drug control: 
Drawing lessons for the 
future 
 
 
Karen Black & A. O'Gorman 
 
Drug policy dissonance: 
Alternative voices of recovery 
in an abstinence-oriented 
policy environment 
 
 
    
12:15 PM to 1:00 PM The Franz Trautmann Memorial Lecture 
By Angela Me, Chief Research and Trend Analysis Branch-United Nations Office on Drugs and Crime (UNODC) 
Drugs and Development 
 
Chair: Nicola Singleton 
1 :00 PM to 1:15 PM Concluding remarks 
2.00 PM to 5:00 PM Workshop 1: Civil Society Involvement in Drug Policy- what can we learn from each other from a research, policy and civil society 
perspective (Eberhard Schatz) – R1-14  
2.00 PM to 5:00 PM Workshop 2: Improving the creation and use of legal data in comparative drug and alcohol policy research (Scott Burris, Caitlin 
Hughes & Rosalie Liccardo Pacula) – R1-15 
2.30 PM to 6:00 PM “Symposium sur la recherche scientifique et l’action publique en matière de drogues” (press event in French organized by Médecins 
du Monde, Fédération Addiction, and the EHESS D3S (Sciences Sociales, Drogues et Société) Programme – R2-01 
 
